Bank Of New York Mellon Corp Intellia Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$33.3 - $44.82 $12.3 Million - $16.5 Million	367,938 New	367,938 $13.7 Billion
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $12.6 Million - $23.7 Million	378,750 New	378,750 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $2.28 Million - $3.03 Million	42,208 Added 14.08%	341,947 $19.1 Million
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $198,916 - $393,853	5,168 Added 1.75%	299,739 $15.5 Million
Q1 2022 May 11, 2022	SELL	$58.27 - $118.99 $66,893 - $136,600	-1,148 Reduced 0.39%	294,571 $21.4 Million
Q4 2021 Feb 11, 2022	SELL	$100.76 - $138.36 $325,051 - $446,349	-3,226 Reduced 1.08%	295,719 $35 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $4.74 Million - $6.33 Million	35,830 Added 13.62%	298,945 $40.1 Million
Q2 2021 Aug 11, 2021	BUY	$60.88 - $161.91 $3.66 Million - $9.74 Million	60,187 Added 29.66%	263,115 $42.6 Million
Q1 2021 May 13, 2021	SELL	$46.59 - $83.68 $81,439 - $146,272	-1,748 Reduced 0.85%	202,928 $16.3 Million
Q4 2020 Feb 09, 2021	BUY	$18.83 - $63.53 $314,592 - $1.06 Million	16,707 Added 8.89%	204,676 $11.1 Million
Q3 2020 Nov 12, 2020	BUY	$17.47 - $24.93 $23,759 - $33,904	1,360 Added 0.73%	187,969 $3.74 Million
Q2 2020 Aug 12, 2020	BUY	$11.14 - $22.87 $151,983 - $312,015	13,643 Added 7.89%	186,609 $3.92 Million
Q1 2020 May 06, 2020	SELL	$9.44 - $15.58 $481,449 - $794,595	-51,001 Reduced 22.77%	172,966 $2.12 Million
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $97,676 - $165,479	9,365 Added 4.36%	223,967 $3.29 Million
Q3 2019 Nov 07, 2019	BUY	$13.07 - $18.51 $868,762 - $1.23 Million	66,470 Added 44.87%	214,602 $2.86 Million
Q2 2019 Aug 12, 2019	BUY	$13.88 - $18.41 $310,717 - $412,126	22,386 Added 17.8%	148,132 $2.43 Million
Q1 2019 May 14, 2019	BUY	$12.79 - $17.62 $37,027 - $51,009	2,895 Added 2.36%	125,746 $2.15 Million
Q4 2018 Feb 11, 2019	SELL	$11.39 - $27.13 $93,398 - $222,466	-8,200 Reduced 6.26%	122,851 $1.68 Million
Q3 2018 Nov 09, 2018	BUY	$25.78 - $32.6 $194,819 - $246,358	7,557 Added 6.12%	131,051 $0
Q2 2018 Aug 06, 2018	BUY	$20.02 - $30.79 $881,180 - $1.36 Million	44,015 Added 55.38%	123,494 $3.38 Million
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $119,591 - $215,117	6,155 Added 8.39%	79,479 $1.68 Million
Q4 2017 Feb 09, 2018	BUY	$17.39 - $31.12 $1.28 Million - $2.28 Million	73,324	73,324 $1.41 Million

Others Institutions Holding NTLA

# of Institutions

317

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$135 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$106 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$105 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$56.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$54.4 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $835M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account